UCLA researchers developed the technique and measuring device UCLA biophysicists have developed a new method to rapidly determine a single cell’s stiffness and size — which could ultimately lead to improved treatments for cancer and other diseases.
Molecule produced by UCLA chemists drove international research collaboration A synthetic version of a rare toxin produced by a sea creature appears to hold promise for treating many different types of cancer while minimizing the harmful side effects of widely … Continue reading →
North Carolina State University researchers have a developed a technique for efficiently producing nanoscale gold rods in large quantities while simultaneously controlling the dimensions of the nanorods and their optical properties. The optical properties of gold nanorods make them desirable … Continue reading →
Scientists create nanoscale vehicle to battle cancer without harming healthy cells A tiny capsule invented at a UCLA lab could go a long way toward improving cancer treatment. Devising a method for more precise and less invasive treatment of cancer … Continue reading →
As cancer treatment in pill form transforms how care is delivered, a new Michigan State University study underscores the challenges patients face in administering their own chemotherapy outside the supervised environment of a cancer clinic. Chemotherapy pills can target specific … Continue reading →
A daily glass of grapefruit juice lets patients derive the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself, according to a new clinical trial. The combination … Continue reading →
Taking a sample from just one part of a tumour may not give a full picture of its‘genetic landscape’, according to a study published in the New England Journal of Medicine. The findings could help explain why attempts at using … Continue reading →
Patients with metastatic melanoma taking the recently approved drug vemurafenib (marketed as Zelboraf) responded well to the twice-daily pill, but some of them developed a different, secondary skin cancer. Now, researchers at UCLA’s Jonsson Comprehensive Cancer Center, working with investigators … Continue reading →